MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
First Among Equals
Professor Roger Greenhalgh, Professor Janet Powell, and Louise Brown address outside interpretations of the design and conclusions of the EVAR-2 trial.
By Professor Roger Greenhalgh, Professor Janet Powell, and Louise Brown
UK EVAR Trials Published and Presented at Charing Cross Symposium
April 11, 2010 — Principal investigator Professor Roger Greenhalgh, MD, and trial manager Louise C. Brown, PhD, presented the 10-year follow-up results from the United Kingdom's EVAR 1 and EVAR 2 trials of endovascular aneurysm repair (EVAR) versus open repair of abdominal aortic aneurysm (AAA) at the Charing Cross International Symposium in London. The findings were also published online ahead of print in the New England Journal of Medicine. EVAR 1 studied patients deemed fit for open surgical repair, and EVAR 2 studied patients deemed unfit for open surgical repair.
UK EVAR Trials Published and Presented at Charing Cross
April 11, 2010—The 10-year follow-up results from the United Kingdom's EVAR 1 and EVAR 2 trials of endovascular aneurysm repair (EVAR) versus open repair of abdominal aortic aneurysm (AAA) were published online ahead of print in the New England Journal of Medicine.
Hemorrhoid Embolization: Does It Last?
A review of available nonsurgical minimally invasive treatments for hemorrhoids and their outcomes compared to hemorrhoidal artery embolization.
By Vincent Vidal, MD, PhD
Ischemic and Venous Wound Identification: What We Look For
Using macro- and microcirculatory characteristics, noninvasive and invasive tests, and available imaging to accurately diagnose and treat arterial and venous ulcers.
By Vlad A. Alexandrescu, MD; Pascal Deleeuw, MD; and Jean-Sébastien Kovanda, MD
Down and Dirty With Dosimetry
A practical understanding and approach to radioembolization.
By David M. Liu, MD, FRCPC, FSIR; Mark Westcott, MD; Ricardo Garcia-Monaco, MD, PhD, FSIR; Robert Abraham, MD, FRCPC, FSIR; and Ripal Gandhi, MD, FSVM
For Whom the Bell Tolls
By Tara M. Mastracci, MD, FRCSC, and Gustavo S. Oderich, MD
WAIS at 55: Wellness and Progress
Ahead of the Western Angiographic & Interventional Society’s 55th anniversary, WAIS leadership discuss the society’s origins and goals for the future, the value of a regional-based meeting, the importance of focusing on physician wellness, and what to expect at the annual meeting in September.
With Sabeen Dhand, MD; John D. Louie, MD; and Susan Jackson, MBA
Deep Venous Disease Patient Advocacy
Moderator Suresh Vedantham, MD, asks Leslie Lake, Volunteer President of the National Blood Clot Alliance and bilateral PE survivor, about patient and physician engagement in the organization, educational and outreach initiatives in deep vein thrombosis/pulmonary embolism, how physicians can get involved in patient advocacy, and more.
Ask the Experts: What Factors Most Influence Your ALI Therapy Decisions?
Experts weigh in on how the patient, anatomy, and technology shape ALI treatment choices.
With Dejah R. Judelson, MD; Britt H. Tonnessen, MD, FSVS, FACS; and Alexander Ushinsky, MD
